NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
About this episode
Jerry Avorn discusses the impact of litigation on health-related product safety.
Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:421-423.
People in this episode
Host: Stephen Morrissey
Guest: Jerry Avorn
Topics covered
- litigation
- health risks
- product safety
- medicine
- regulation
Keywords
- litigation
- health risks
- product safety
- regulation
- medicine
Mentioned in this episode
Organizations: Harvard Medical School, Brigham and Women’s Hospital, N Engl J Med
Books & works: Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
More episodes of NEJM Interviews
- NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
- NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
- NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
- NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
- NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
- NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
Explore listener stats, chart rankings, contacts and more on the NEJM Interviews podcast page.